Frequent Needle Exchange Use and HIV Incidence in Vancouver, Canada

American Journal of Medicine

Volumn 120, Issue 2, 2007, Pages 172-179

  Wood, Evan ^a,b   Lloyd Smith, Elisa ^a,b   Li, Kathy ^a   Strathdee, Steffanie A ^c   Small, Will ^a   Tyndall, Mark W ^a,b   Montaner, Julio S G ^a,b   Kerr, Thomas ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; Canada; HIV; Needle exchange; Prevention; Vancouver

Indexed keywords

COCAINE; DIAMORPHINE; METHADONE;

ADULT; ARTICLE; CANADA; CLINICAL OBSERVATION; DRUG ABUSE; EPIDEMIC; FEMALE; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NEEDLE; NEEDLE EXCHANGE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SEROCONVERSION;

BRITISH COLUMBIA; COCAINE-RELATED DISORDERS; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; KAPLAN-MEIERS ESTIMATE; MULTIVARIATE ANALYSIS; NEEDLE-EXCHANGE PROGRAMS; ODDS RATIO; RISK FACTORS; TIME FACTORS;

EID: 33846589923     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.02.030     Document Type: Article

References (39)

1. Hamers F.F., and Downs A.M. HIV in central and eastern Europe. Lancet 361 (2003) 1035-1044
2. Kitayaporn D., Uneklabh C., Weniger B.G., et al. HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand. AIDS 8 (1994) 1443-1450
3. Des Jarlais D.C., Hagan H., Friedman S.R., et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 274 (1995) 1226-1231
4. Bluthenthal R.N., Kral A.H., Gee L., Erringer E.A., and Edlin B.R. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS 14 (2000) 605-611
5. Wood E., Tyndall M.W., Spittal P.M., et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS 16 (2002) 941-943
6. Des Jarlais D.C., Marmor M., Paone D., et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 348 (1996) 987-991
7. Hurley S.F., Jolley D.J., and Kaldor J.M. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 349 (1997) 1797-1800
8. Heimer R., Kaplan E.H., Khoshnood K., Jariwala B., and Cadman E.C. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. Am J Med 95 (1993) 214-220
9. Vlahov D., Des Jarlais D.C., Goosby E., et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol 154 12 Suppl (2001) S70-S77
10. Normand J., Vlahov D., and Moses L.E. Preventing HIV Transmission: The Role of Sterile Needles and Bleach (1995), National Academy Press, Washington, DC
11. Lurie P., and Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet. 349 (1997) 604-608
12. Kerr T., Kaplan K., Suwannawong P., Jurgens R., and Wood E. The Global Fund to Fight AIDS, Tuberculosis and Malaria: funding for unpopular public-health programmes. Lancet 364 (2004) 11-12
13. Wolfe D., and Malinowska-Sempruch K. A working paper commissioned by the HIV/AIDS Task Force of the Millennium Project. Illicit drug policies and the global HIV epidemic: effects of UN and national government approaches (2004), Open Society Institute, New York, NY. http://www.soros.org/initiatives/health/focus/ihrd/articles_publications/publications/cnd_20040316 Available at: http://www.soros.org/initiatives/health/focus/ihrd/articles_publications/publications/cnd_20040316. Accessed January 23, 2006.
14. Strathdee S.A., Patrick D.M., Currie S.L., et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 11 (1997) F59-F65
15. Task Force Report on a Site Visit to Vancouver (1998), Office of National Drug Control Policy, Executive Office of the President, Washington, DC
16. Bellm J. Needle-exchange programmes are not the answer. Lancet 353 (1999) 1657-1661
17. Moss A.R. For God's sake, don't show this letter to the president .... [comment]. Am J Public Health 90 (2000) 1395-1396
18. Coutinho R.A. Needle exchange, pragmatism, and moralism. Am J Public Health 90 (2000) 1387-1388
19. Souder, Mark E. Souder to NIH: Harm Reduction Causes Harm [letter]. April 27, 2004. Available at: http://www.drugpolicy.org/library/05_06_04souder.cfm. Accessed January 23, 2006.
20. Bennett S.S. Harm reduction and needle exchange programmes. Lancet 351 (1998) 1819
21. Deadly ignorance. Washington Post (2005) B6 February 27
22. Phillips M.M. Bush ties money for AIDS work to a policy pledge. Wall Street Journal (2005) A3 February 28
23. Ideology and AIDS. [editorial]. New York Times (2005) February 26
24. Schechter M.T., Strathdee S.A., Cornelisse P.G., et al. Do needle exchange programmes increase the spread of HIV among injection drug users?. An investigation of the Vancouver outbreak. AIDS 13 (1999) F45-F51
25. Tyndall M.W., Currie S., Spittal P., et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 17 (2003) 887-893
26. Miller C.L., Spittal P.M., LaLiberte N., et al. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr 30 (2002) 335-341
27. Wood E., Tyndall M.W., Spittal P., et al. Needle exchange and difficulty with needle access during an ongoing HIV epidemic. Int J Drug Policy 13 (2002) 95-102
28. Chaisson R.E., Bacchetti P., Osmond D., Brodie B., Sande M.A., and Moss A.R. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 261 (1989) 561-565
29. Schoenbaum E.E., Hartel D., Selwyn P.A., et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med 321 (1989) 874-879
30. Corneil T.A., Kuyper L.M., Shoveller J., et al. Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health Place 12 (2006) 79-85
31. Kuyper L.M., Palepu A., Kerr T., et al. Factors associated with sex-trade involvement among female injection drug users in a Canadian setting. Addict Res Theory 13 (2005) 193-199
32. Wood E., Spittal P., Li K., et al. Inability to access addiction treatment and risk of HIV infection among injection drug users. J Acquir Immune Defic Syndr 36 (2004) 750-754
33. Spittal P.M., Small W., Wood E., et al. How otherwise dedicated AIDS prevention workers come to support state-sponsored shortage of clean syringes in Vancouver, Canada. Int J Drug Policy 15 (2004) 36-45
34. Wood E., Tyndall M.W., Spittal P.M., et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?. CMAJ 165 (2001) 405-410
35. Elliott R., Csete J., Palepu A., and Kerr T. Reason and rights in global drug control policy. CMAJ 172 (2005) 655-656
36. "Thematic topic: HIV/AIDS in the context of drug use." Paper for Intersessional Working Group on Thematic Drug (2nd meeting, 20 October 2004) regarding UN Commission on Narcotic Drugs, 48th Session.
37. Hagan H., McGough J.P., Thiede H., Hopkins S.G., Weiss N.S., and Alexander E.R. Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs. J Urban Health 77 (2000) 103-112
38. Safaeian M., Brookmeyer R., Vlahov D., Latkin C., Marx M., and Strathdee S.A. Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation. Am J Epidemiol 155 (2002) 169-175
39. Lurie P. Invited commentary: le mystère de Montréal. Am J Epidemiol 146 (1997) 1003-1006 discussion 1007-1010